Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Rapid and Reproducible Karyotyping with Nanopore Sequencing in AML Patients

Blood (2022) 140 (Supplement 1): 6070–6072.

https://doi.org/10.1182/blood-2022-163035

Published: 2022

Journal Articles

Integration of Hi-C and Nanopore Sequencing for Structural Variant Analysis in AML with a Complex Karyotype: (Chromothripsis)²

Marius-Konstantin Klever, Eric Sträng, PhD, Julius Jungnitsch, Uirá Souto Melo, Sara Hetzel, Anna Dolnik, Robert Schöpflin, Jens F. Schrezenmeier, Olga Blau, Jörg Westermann, Konstanze Döhner, Hubert Schrezenmeier, Malte Spielmann, Alexander Meissner, PhD, Stefan Mundlos, Lars Bullinger, MD

Blood (2020) 136 (Supplement 1): 28.

https://doi.org/10.1182/blood-2020-133787

Published: 2020

Journal Articles

Early Hyperbilirubinemia Is an Independent Predictor of Outcome after Allogeneic Stem Cell Transplantation and Correlates with Markers of Endothelial Cell Dysfunction

Thomas Luft, MD PhD, Hao Dai, Aleksandar Radujkovic, MD, David Schult, Joshua Majer-Lauterbach, Olga Blau, MD PhD, Lars Bullinger, Sihe Jiang, Carsten Müller-Tidow, MD, Peter Dreger, Olaf Penack, MD

Blood (2019) 134 (Supplement_1): 4487.

https://doi.org/10.1182/blood-2019-124284

Published: 2019

Journal Articles

Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients

Blood (2019) 133 (10): 1140–1151.

https://doi.org/10.1182/blood-2018-05-852822

Published: 2019

Includes: Supplemental data

Journal Articles

Genetic Risk of Severe Chronic Graft-Versus-Host Disease Defined By Host-Derived CXCR3 Ligands

Hao Dai, Sivaramakrishna P. Rachakonda, PhD, Olaf Penack, MD, Aleksandar Radujkovic, MD, Carsten Müller-Tidow, MD, Olga Blau, MD PhD, Igor-Wolfgang Blau, MD PhD, Rajiv Kumar, PhD, Peter Dreger, Thomas Luft, MD PhD

Blood (2018) 132 (Supplement 1): 357.

https://doi.org/10.1182/blood-2018-99-113820

Published: 2018

Journal Articles

Characteristics of DNMT3A- R882 Mutation in AML

Olga Blau, MD PhD, Franziska Behrenbeck, Mirgul Bayanova, MD, Igor-Wolfgang Blau, MD PhD, Lars Bullinger, MD

Blood (2018) 132 (Supplement 1): 5263.

https://doi.org/10.1182/blood-2018-99-116652

Published: 2018

Journal Articles

DNMT3A expression Analysis in AML

Yubin Xing, MD, Franziska Behrenbeck, Mirgul Bayanova, MD, Igor Blau, MD PhD, Lars Bullinger, MD, Olga Blau, MD PhD

Blood (2018) 132 (Supplement 1): 5276.

https://doi.org/10.1182/blood-2018-99-113626

Published: 2018

Journal Articles

Mortality after Allogeneic Stem Cell Transplantation Associates with Gene Polymorphisms in CD40L and Thrombomodulin in the Absence of Statins

Thomas Luft, MD PhD, Sivaramakrishna P. Rachakonda, PhD, Hao Dai, Olaf Penack, MD, Olga Blau, Igor Wolfgang Blau, MD, Aleksandar Radujkovic, MD, Carsten Müller-Tidow, Peter Dreger, MD, Rajive Kumar, PhD

Blood (2017) 130 (Supplement 1): 3244.

https://doi.org/10.1182/blood.V130.Suppl_1.3244.3244

Published: 2017

Journal Articles

Prognostic Impact of Distinct Combinations of Molecular Mutations in AML Patients. Results of Two-Center International Cooperation Study

Olga Blau, MD PhD, Irina Martynkevich, MD PhD, Franziska Behrenbeck, Claudia D. Baldus, MD, Ekaterina Motiko, Sergei Voloshin, MD PhD, Antonio Pezzutto, MD PhD, Bernd Dorken, MD PhD, Igor Wolfgang Blau, MD PhD

Blood (2017) 130 (Supplement 1): 5111.

https://doi.org/10.1182/blood.V130.Suppl_1.5111.5111

Published: 2017

Journal Articles

DNMT3A Mutations in AML Patients: Prognostic Impact and Comparative Analysis of Mutations Burden in Diagnostic Samples, after Standard Therapy, and after Allogeneic Stem Cell Transplantation

Olga Blau, MD PhD, Franziska Behrenbeck, Nikola Suckert, Lars R. Fransecky, MD, Claudia D. Baldus, MD, Renate Arnold, MD PhD, Antonio Pezzutto, MD PhD, Bernd Dörken, MD PhD, Igor Wolfgang Blau, MD PhD

Blood (2016) 128 (22): 2891.

https://doi.org/10.1182/blood.V128.22.2891.2891

Published: 2016

Journal Articles

Quantitative Detection of DNMT3A R882H Mutation in Course of Treatment of Acute Myeloid Leukemia Patients

Olga Blau, MD PhD, Rimma Berenstein, Claudia Baldus, MD PhD, Nikola Suckert, Kathrin Rieger, MD, Axel Nogai, MD, Antonio Pezzutto, MD PhD, Bernd Doerken, MD PhD, Igor Wolfgang Blau, MD PhD

Blood (2015) 126 (23): 4970.

https://doi.org/10.1182/blood.V126.23.4970.4970

Published: 2015

Journal Articles

SIRT3 Modulates Mitochondrial Stress Response in Bone Marrow Mesenchymal Stromal Cells of Multiple Myeloma Patients

Rimma Berenstein, Igor Wolfgang Blau, MD PhD, Axel Nogai, MD, Marlies Waechter, Martin Schmidt-Hieber, MD PhD, Antonio Pezzutto, MD PhD, Bernd Doerken, MD PhD, Olga Blau, MD PhD

Blood (2015) 126 (23): 5325.

https://doi.org/10.1182/blood.V126.23.5325.5325

Published: 2015

Journal Articles

Profiling of somatic mutations in acute myeloid leukemia with FLT3 -ITD at diagnosis and relapse

Blood (2015) 126 (22): 2491–2501.

https://doi.org/10.1182/blood-2015-05-646240

Published: 2015

Includes: Supplemental data

Journal Articles

Cyclin D1 C.870G>a Polymorphism in Patients with Multiple Myeloma after Allogeneic Stem Cells Transplantation

Olga Blau, MD PhD, Ekaterina Slonova, Rimma Berenstein, Axel Nogai, MD, Kathrin Rieger, MD, Antonio Pezzutto, MD PhD, Bernd Dörken, MD PhD, Igor Wolfgang Blau, MD PhD

Blood (2014) 124 (21): 2576.

https://doi.org/10.1182/blood.V124.21.2576.2576

Published: 2014

Journal Articles

Multiple Myeloma Cells Induce Mitochondrial Stress Response in Bone Marrow Mesenchymal Stromal Cells

Rimma Berenstein, Olga Blau, MD PhD, Axel Nogai, MD, Marlies Wächter, Martin Schmidt-Hieber, MD, Antonio Pezzutto, MD PhD, Bernd Dörken, MD PhD, Igor Wolfgang Blau, MD PhD

Blood (2014) 124 (21): 3357.

https://doi.org/10.1182/blood.V124.21.3357.3357

Published: 2014

Journal Articles

Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT

Angela Mensen, Korinna Jöhrens, Ioannis Anagnostopoulos, Sonya Demski, Maike Oey, Andrea Stroux, Philipp Hemmati, Jörg Westermann, Olga Blau, Friedrich Wittenbecher, Kamran Movassaghi, Martin Szyska, Sybill Thomas, Bernd Dörken, Carmen Scheibenbogen, Renate Arnold, Il-Kang Na

Blood (2014) 124 (6): 963–972.

https://doi.org/10.1182/blood-2013-11-539031

Published: 2014

Includes: Supplemental data

Journal Articles

DNMT3A Mutations In AML: Incidence, Prognostic Influence and Association With Other Molecular Markers

Igor Wolfgang Blau, MD, PhD, Rimma Berenstein, Claudia D. Baldus, MD, PhD, Sophie Schlabitz, Asiye Kar, Ruhiye Cay, Annette Sindram, Claudia Seide, Antonio Pezzutto, Bernd Dörken, MD, PhD, Olga Blau, MD, PhD

Blood (2013) 122 (21): 2627.

https://doi.org/10.1182/blood.V122.21.2627.2627

Published: 2013

Journal Articles

Aberrant Expression Of miRNA and mRNA Of Cell Cycle and Adhesion-Related Genes In Bone Marrow Stroma Cells Derived From Patients With Multiple Myeloma

Rimma Berenstein, Blau Igor Wolfgang, MD, PhD, Axel Nogai, MD, Marlies Wächter, Antonio Pezzutto, MD, PhD, Bernd Dörken, MD, PhD, Olga Blau, MD, PhD

Blood (2013) 122 (21): 3149.

https://doi.org/10.1182/blood.V122.21.3149.3149

Published: 2013

Journal Articles

Single Nucleotide Polymorphisms Within The Thrombomodulin Gene (THBD) Predict Risk Of Non-Relapse Mortality In Patients With Graft-Versus-Host Disease

Thomas Luft, MD, PhD, Olaf Penack, MD, Olga Blau, MD, PhD, Sascha Dietrich, MD, Berend H. Isermann, MD, Anthony D Ho, MD, Lutz Uharek, Peter Dreger, MD, Rajive Kumar, PhD, Krishna P.S. Rachakonda, PhD

Blood (2013) 122 (21): 4589.

https://doi.org/10.1182/blood.V122.21.4589.4589

Published: 2013

Journal Articles

Acute Bone Marrow GvHD Is Associated With Delayed B Cell Neogenesis and Impaired Natural Antibody Response After Allogeneic Hematopoietic Stem Cell Transplantation

Angela Mensen, Korinna Jöhrens, Ioannis Anagnostopoulos, Sonya Demski, Christoph Ochs, Philipp Hemmati, MD, Giang Lam Vuong, MD, Kathrin Rieger, Olga Blau, Jörg Westermann, MD, Bernd Dörken, Carmen Scheibenbogen, Renate Arnold, Il-Kang Na

Blood (2013) 122 (21): 4605.

https://doi.org/10.1182/blood.V122.21.4605.4605

Published: 2013

NARROW

Rapid and Reproducible Karyotyping with Nanopore Sequencing in AML Patients

Integration of Hi-C and Nanopore Sequencing for Structural Variant Analysis in AML with a Complex Karyotype: (Chromothripsis)²

Early Hyperbilirubinemia Is an Independent Predictor of Outcome after Allogeneic Stem Cell Transplantation and Correlates with Markers of Endothelial Cell Dysfunction

Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients

Genetic Risk of Severe Chronic Graft-Versus-Host Disease Defined By Host-Derived CXCR3 Ligands

Characteristics of DNMT3A- R882 Mutation in AML

DNMT3A expression Analysis in AML

Mortality after Allogeneic Stem Cell Transplantation Associates with Gene Polymorphisms in CD40L and Thrombomodulin in the Absence of Statins

Prognostic Impact of Distinct Combinations of Molecular Mutations in AML Patients. Results of Two-Center International Cooperation Study

DNMT3A Mutations in AML Patients: Prognostic Impact and Comparative Analysis of Mutations Burden in Diagnostic Samples, after Standard Therapy, and after Allogeneic Stem Cell Transplantation

Quantitative Detection of DNMT3A R882H Mutation in Course of Treatment of Acute Myeloid Leukemia Patients

SIRT3 Modulates Mitochondrial Stress Response in Bone Marrow Mesenchymal Stromal Cells of Multiple Myeloma Patients

Profiling of somatic mutations in acute myeloid leukemia with FLT3 -ITD at diagnosis and relapse

Cyclin D1 C.870G>a Polymorphism in Patients with Multiple Myeloma after Allogeneic Stem Cells Transplantation

Multiple Myeloma Cells Induce Mitochondrial Stress Response in Bone Marrow Mesenchymal Stromal Cells

Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT

DNMT3A Mutations In AML: Incidence, Prognostic Influence and Association With Other Molecular Markers

Aberrant Expression Of miRNA and mRNA Of Cell Cycle and Adhesion-Related Genes In Bone Marrow Stroma Cells Derived From Patients With Multiple Myeloma

Single Nucleotide Polymorphisms Within The Thrombomodulin Gene (THBD) Predict Risk Of Non-Relapse Mortality In Patients With Graft-Versus-Host Disease

Acute Bone Marrow GvHD Is Associated With Delayed B Cell Neogenesis and Impaired Natural Antibody Response After Allogeneic Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only